Day

november 21, 2018
Cambridge, UK and Indianapolis, US – 21 November 2018: Acacia Pharma Group plc (“Acacia Pharma”, the “Company”) (EURONEXT: ACPH) announces that data and analyses from its positive Phase 3 clinical trial of BARHEMSYS(TM) (intravenous amisulpride) as rescue treatment of established post-operative nausea & vomiting (PONV) have been published (Habib et al1) in the online edition...

Nyheder

Danske forskere bringer nyt om overvældende søvntrang 
19. februar 2019
Hidtil største studie knytter såkaldt kattelort-parasit til skizofreni
2. februar 2019
Forskere finder sammenhænge mellem psykiatriske lidelser og begivenheder i fostertilstanden
28. januar 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge